About

Us

Our Vision

To enable personalized and effective treatment for every cancer patient.

Our Mission

To harness the power of AI to transform cancer prognosis, delivering accurate, actionable insights that improve patient outcomes.

Our Journey

2018

Breakthrough Discovery

Set the foundation for modern computational pathology within our university research groups

2018

2023

Company Founded

Established StratifAI to revolutionize AI-based cancer prognosis.

2023

2024/23

CDL Accelerator Program

Participated in the Creative Destruction Lab (CDL) Accelerator Program.

2023/24

2024

Pre-Seed Funding

Raised pre-seed funding to accelerate our time to market.

Our Journey

2018

Breakthrough Discovery

Set the foundation for modern computational pathology within our university research groups

2018

2023

Company Founded

Established StratifAI to revolutionize AI-based cancer prognosis.

2023

2024/23

CDL Accelerator Program

Participated in the Creative Destruction Lab (CDL) Accelerator Program.

2023/24

2024

Pre-Seed Funding

Raised pre-seed funding to accelerate our time to market.

Our Leadership Team

Omar El Nahhas, M.Sc.

Chief Executive Officer & Co-Founder

Firas Khader, M.Sc., PhD

Chief Technology Officer & Co-Founder

Jakob Nikolas Kather, MD

Scientific Advisor
& Co-Founder

Daniel Truhn, MD, PhD

Scientific Advisor
& Co-Founder

Meet our Partners

Our Investors

We have successfully secured funding to accelerate and make precision oncology available to the masses

About

Us

Our Vision

Our Mission

Our Journey

Our Journey

Our Leadership Team

Omar El Nahhas, M.Sc.

Firas Khader, M.Sc., PhD

Jakob Nikolas Kather, MD

Daniel Truhn, MD, PhD

Meet our Partners

Our Investors

Join us in our effort to bring personalized treatment to every cancer patient.

Stay in touch

Product

Service

Company

Information

Non-CE-IVD marked products are currently available for research use only and not for in vitro diagnostic use